I calcioantagonisti inibiscono la perossidazione delle lipoproteine umane a bassa densità indotta dai radicali liberi dell'ossigeno in vitro.

Translated title of the contribution: Calcium channel blockers inhibit human low-density lipoprotein peroxidation induced by oxygen free radicals in vitro

C. Napoli, G. Ambrosio, G. Palumbo, P. Chiariello, M. Chiariello

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Previous studies have shown that calcium-antagonists may reduce the development of experimental atherosclerosis, and that nifedipine may slow progression of coronary atherosclerosis in man. The mechanisms responsible for this effect are still unclear. It has been recently proposed that oxygen-free radicals can induce peroxidation of human low-density lipoproteins (LDL), and that peroxidized LDL may be an atherogenic stimulus. Chemical modified LDL are internalized by macrophages via specific cell surface receptor that was termed the scavenger receptor, and could induce foam cells transformation in vivo. Previous studies on other systems have shown that calcium-antagonists may effectively inhibit oxygen radical-induced lipid peroxidation. These drugs, though differing widely in their chemical structure, are lipophilic to various degrees and presumably would concentrate in the lipid domain of the phospholipid-rich membranes. Therefore, the aim of the present study was to investigate whether calcium-channel blockers may reduce human LDL peroxidation. Purified human LDL were exposed to oxygen radicals generated by xanthine-xanthine oxidase (18 hours) after a pre-incubation (30 min) in presence of different concentrations of nifedipine, diltiazem and verapamil. Peroxidation was measured from malonyldialdehyde production. The results show that calcium-antagonists prevent LDL peroxidation. Thus, calcium-antagonists may reduce peroxidation of human LDL in vitro, at clinically relevant concentrations. These data suggest that reduced formation of atherogenic peroxidized LDL may be an additional mechanism for the anti-atherosclerotic effects of calcium-antagonists in vivo.

Original languageItalian
Pages (from-to)801-804
Number of pages4
JournalCardiologia
Volume37
Issue number11
Publication statusPublished - Nov 1992

Fingerprint

Calcium Channel Blockers
LDL Lipoproteins
Free Radicals
Reactive Oxygen Species
Calcium
Nifedipine
Scavenger Receptors
Foam Cells
Xanthine
In Vitro Techniques
Diltiazem
Xanthine Oxidase
Cell Surface Receptors
Verapamil
Malondialdehyde
Lipid Peroxidation
Coronary Artery Disease
Phospholipids
Atherosclerosis
Macrophages

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

I calcioantagonisti inibiscono la perossidazione delle lipoproteine umane a bassa densità indotta dai radicali liberi dell'ossigeno in vitro. / Napoli, C.; Ambrosio, G.; Palumbo, G.; Chiariello, P.; Chiariello, M.

In: Cardiologia, Vol. 37, No. 11, 11.1992, p. 801-804.

Research output: Contribution to journalArticle

Napoli, C. ; Ambrosio, G. ; Palumbo, G. ; Chiariello, P. ; Chiariello, M. / I calcioantagonisti inibiscono la perossidazione delle lipoproteine umane a bassa densità indotta dai radicali liberi dell'ossigeno in vitro. In: Cardiologia. 1992 ; Vol. 37, No. 11. pp. 801-804.
@article{9470840b10e04a8e90e6bc2e05ff7266,
title = "I calcioantagonisti inibiscono la perossidazione delle lipoproteine umane a bassa densit{\`a} indotta dai radicali liberi dell'ossigeno in vitro.",
abstract = "Previous studies have shown that calcium-antagonists may reduce the development of experimental atherosclerosis, and that nifedipine may slow progression of coronary atherosclerosis in man. The mechanisms responsible for this effect are still unclear. It has been recently proposed that oxygen-free radicals can induce peroxidation of human low-density lipoproteins (LDL), and that peroxidized LDL may be an atherogenic stimulus. Chemical modified LDL are internalized by macrophages via specific cell surface receptor that was termed the scavenger receptor, and could induce foam cells transformation in vivo. Previous studies on other systems have shown that calcium-antagonists may effectively inhibit oxygen radical-induced lipid peroxidation. These drugs, though differing widely in their chemical structure, are lipophilic to various degrees and presumably would concentrate in the lipid domain of the phospholipid-rich membranes. Therefore, the aim of the present study was to investigate whether calcium-channel blockers may reduce human LDL peroxidation. Purified human LDL were exposed to oxygen radicals generated by xanthine-xanthine oxidase (18 hours) after a pre-incubation (30 min) in presence of different concentrations of nifedipine, diltiazem and verapamil. Peroxidation was measured from malonyldialdehyde production. The results show that calcium-antagonists prevent LDL peroxidation. Thus, calcium-antagonists may reduce peroxidation of human LDL in vitro, at clinically relevant concentrations. These data suggest that reduced formation of atherogenic peroxidized LDL may be an additional mechanism for the anti-atherosclerotic effects of calcium-antagonists in vivo.",
author = "C. Napoli and G. Ambrosio and G. Palumbo and P. Chiariello and M. Chiariello",
year = "1992",
month = "11",
language = "Italian",
volume = "37",
pages = "801--804",
journal = "Cardiologia (Rome, Italy)",
issn = "0393-1978",
publisher = "Societa Italiana di Cardiologia",
number = "11",

}

TY - JOUR

T1 - I calcioantagonisti inibiscono la perossidazione delle lipoproteine umane a bassa densità indotta dai radicali liberi dell'ossigeno in vitro.

AU - Napoli, C.

AU - Ambrosio, G.

AU - Palumbo, G.

AU - Chiariello, P.

AU - Chiariello, M.

PY - 1992/11

Y1 - 1992/11

N2 - Previous studies have shown that calcium-antagonists may reduce the development of experimental atherosclerosis, and that nifedipine may slow progression of coronary atherosclerosis in man. The mechanisms responsible for this effect are still unclear. It has been recently proposed that oxygen-free radicals can induce peroxidation of human low-density lipoproteins (LDL), and that peroxidized LDL may be an atherogenic stimulus. Chemical modified LDL are internalized by macrophages via specific cell surface receptor that was termed the scavenger receptor, and could induce foam cells transformation in vivo. Previous studies on other systems have shown that calcium-antagonists may effectively inhibit oxygen radical-induced lipid peroxidation. These drugs, though differing widely in their chemical structure, are lipophilic to various degrees and presumably would concentrate in the lipid domain of the phospholipid-rich membranes. Therefore, the aim of the present study was to investigate whether calcium-channel blockers may reduce human LDL peroxidation. Purified human LDL were exposed to oxygen radicals generated by xanthine-xanthine oxidase (18 hours) after a pre-incubation (30 min) in presence of different concentrations of nifedipine, diltiazem and verapamil. Peroxidation was measured from malonyldialdehyde production. The results show that calcium-antagonists prevent LDL peroxidation. Thus, calcium-antagonists may reduce peroxidation of human LDL in vitro, at clinically relevant concentrations. These data suggest that reduced formation of atherogenic peroxidized LDL may be an additional mechanism for the anti-atherosclerotic effects of calcium-antagonists in vivo.

AB - Previous studies have shown that calcium-antagonists may reduce the development of experimental atherosclerosis, and that nifedipine may slow progression of coronary atherosclerosis in man. The mechanisms responsible for this effect are still unclear. It has been recently proposed that oxygen-free radicals can induce peroxidation of human low-density lipoproteins (LDL), and that peroxidized LDL may be an atherogenic stimulus. Chemical modified LDL are internalized by macrophages via specific cell surface receptor that was termed the scavenger receptor, and could induce foam cells transformation in vivo. Previous studies on other systems have shown that calcium-antagonists may effectively inhibit oxygen radical-induced lipid peroxidation. These drugs, though differing widely in their chemical structure, are lipophilic to various degrees and presumably would concentrate in the lipid domain of the phospholipid-rich membranes. Therefore, the aim of the present study was to investigate whether calcium-channel blockers may reduce human LDL peroxidation. Purified human LDL were exposed to oxygen radicals generated by xanthine-xanthine oxidase (18 hours) after a pre-incubation (30 min) in presence of different concentrations of nifedipine, diltiazem and verapamil. Peroxidation was measured from malonyldialdehyde production. The results show that calcium-antagonists prevent LDL peroxidation. Thus, calcium-antagonists may reduce peroxidation of human LDL in vitro, at clinically relevant concentrations. These data suggest that reduced formation of atherogenic peroxidized LDL may be an additional mechanism for the anti-atherosclerotic effects of calcium-antagonists in vivo.

UR - http://www.scopus.com/inward/record.url?scp=0026950603&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026950603&partnerID=8YFLogxK

M3 - Articolo

C2 - 1298553

AN - SCOPUS:0026950603

VL - 37

SP - 801

EP - 804

JO - Cardiologia (Rome, Italy)

JF - Cardiologia (Rome, Italy)

SN - 0393-1978

IS - 11

ER -